Global Cell And Tissue Culture Supplies Market Insights Forecasts to 2030

• The global cell and tissue culture supplies market was valued at USD 21.9 billion in 2021.
• The market is growing at a CAGR of 11.5% from 2022 to 2030
• The global cell and tissue culture supplies market is expected to reach USD 58.3 billion by 2030
• Asia-Pacific is expected to grow the fastest during the forecast period

The global cell and tissue culture supplies market is expected to reach USD 58.3 billion by 2030, at a CAGR of 11.5% during the forecast period 2022 to 2030. The cell and tissue culture supplies market has grown due to the demand for artificial organs and biopharmaceuticals. In addition, R&D activities are increasing along with the use of cell and tissue cultures.

Market Overview

In a nutshell, maintaining living cells in a source is what a cell culture entails. By providing the proper conditions under in vitro settings, cell culture systems aim to culture and investigate the cells that are in a three-dimensional environment in tissues. Cell culture applications cover a wide range of situations. The manufacture of monoclonal antibodies, vaccines, enzymes, hormones, interleukin, and certain growth factors are only a few of the applications for cell culture. Additionally, cell culture research is useful in a wide range of sectors, including toxicological research, the creation of new medications, and cell or stem cell therapy techniques.

Covid-19 surprised a lot of countries. It served as a wake-up call for numerous nations to begin making preparations for such lethal biological viruses that have an adverse long-term effect on the general populace and the country's overall economy. The foundation of the global healthcare infrastructure has always been researched and developed. Still, it became even more important after 2020, forcing governments, businesses, and international healthcare organizations to promote as much study as possible on the connections between and effects that coexisting organisms have on one another.

This is possible only by creating the cell and tissue cultures outside their natural sources and analyzing them in various situations while maintaining them in artificial medical environments. Setting up a facility that can grow cells or tissues is expensive. Many undeveloped or developing countries may find it difficult to buy some costly equipment needed for the operation. Even though these countries can establish a small number of cell and tissue culture facilities, their need for significant financing to develop further research facilities is expected to limit the growth of the worldwide cell and tissue culture supplies market.

Report Coverage

This research report categorizes the market for global cell and tissue culture supplies based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global Cell and tissue culture supplies market. Recent market developments and competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each global Cell and tissue culture supplies market sub-segments.

Segmentation Analysis

• In 2021, the incubators segment dominated the market with the largest market share of 40% and market revenue of 8.76 billion.

Based on the instruments, the global cell and tissue culture supplies market are categorized into Biosafety Cabinets, Cryostorage Equipment, Incubators, And Pipetting Instruments. In 2021, the incubators segment dominated the market with the largest market share of 40% and market revenue of 8.76 billion. Incubators are frequently used to investigate tissue cultures, which entail the removal of small pieces of animal or plant tissue.

• In 2021, the Petri dishes segment accounted for the largest share of the market, with 32% and market revenue of 7.0 billion.

Based on the type, the Cell and tissue culture supplies market are categorized into Petri Dishes, Roller Bottle Culture Apparatus, Culture Systems & Bioreactors, Culture Cylinders, Spreaders, Syringe Fillers, Serological Pipettes, Scrapers & Lifters, And Tissue Grinders. In 2021, the Petri dishes segment accounted for the largest share of the market, with 32% and market revenue of 7.0 billion. In laboratories, Petri dishes are frequently used to research microorganisms. It is a shallow cylindrical round glass that is essential for cultivating cultures of cells, viruses, bacteria, and other microbes. These dishes can also be used for other things, such as drying off liquids to remove residue.

• In 2021, the media segment accounted for the largest share of the market, with 35% and a market revenue of 7.6 billion.

Based on the consumables, the Cell and tissue culture supplies market are categorized into Sera, Contamination Detection Kits, Reagents, Media, And Cryoprotective Agents. In 2021, the media segment accounted for the largest share of the market, with 35% and a market revenue of 7.6 billion. Certain inorganic chemicals and inorganic salts make up the chemical or synthetic medium that is used in tissue culture. The growth of the culture medium may also contain several types of tissue cultures and living cells. Two types of media are referred to as special-purpose media: selective media and enriched media.

Regional Segment Analysis of the Cell and Tissue Culture Supplies Market

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, the U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America)
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America emerged as the largest market for the global cell and tissue culture supplies market, with a market share of around 39.1% and 21.9 billion of the market revenue in 2021.

• In 2021, North America emerged as the largest market for the global Cell and tissue culture supplies market, with a market share of around 39.1% and 21.9 billion of the market revenue. This is primarily due to the emergence of significant market participants and the rising desire for individualized treatment. Additionally, because healthcare is one of the nation's top objectives, the US government supports medical research. The Human Cancer Models Initiative, which was unveiled in 2016, has a three-year goal of developing 1,000 novel cell lines for researchers to analyze.

• The Asia-Pacific market is expected to grow at the fastest CAGR between 2021 and 2030, This is a result of the rapid industrialization that is occurring in nations like China, Malaysia, India, and South Korea. Furthermore, Due to expanding government efforts, improvements to healthcare facilities, and increased investment by the major industry participants, the Cell and tissue culture supplies market in Asia Pacific is anticipated to grow over the forecast period.

Competitive Landscape

The report offers the appropriate analysis of the key organizations/companies involved within the global cell and tissue culture supplies market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Market Players:

• Avantor, Inc.
• BD Biosciences
• BioIVT
• Cell Culture Technologies
• Corning Inc.
• GE Healthcare Life Sciences
• Irvine Scientific Inc.
• Lonza Group AG
• Merck Millipore GmbH
• MP Biomedicals LLC
• ORIGIO a/s
• PromoCell GmbH
• Sigma-Aldrich Corporation
• Thermo Fischer Scientific Inc.
• Vitrolife AB

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting And Research Firm
• Venture capitalists
• Third-party knowledge providers
• Value-Added Resellers (VARs)

Some of the Key Developments:

• In June 2022, To improve efficiency and productivity in bioprocesses for manufacturing monoclonal antibodies, vaccines, viral vectors, and therapeutic cells, Evonik introduced the cQrex range of cell culture components.
• In February 2022, Cellular Evolution raised GBP 1.75 million to hasten the introduction of their continuous cell culture technology.

Market Segment

This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global cell and tissue culture supplies market based on the below-mentioned segments:

Global Cell and tissue culture supplies market, By Instruments

• Biosafety Cabinets
• Cryostorage Equipment
• Incubators
• Pipetting Instruments

Global Cell and tissue culture supplies market, By Type

• Petri Dishes
• Roller Bottle Culture Apparatus
• Culture Systems & Bioreactors
• Culture Cylinders
• Spreaders
• Syringe Fillers
•  Serological Pipettes
• Scrapers & Lifters
• Tissue Grinders

Global Cell and tissue culture supplies market, By Consumables

• Sera
•  Contamination Detection Kits
• Reagents
• Media
•  Cryoprotective Agents

Global Cell and tissue culture supplies market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa